Atieh Pourbagheri‐Sigaroodi

Small molecule inhibitor of TLR4 inhibits ovarian cancer cell proliferation: new insight into the anticancer effect of TAK-242 (Resatorvid)

Bahareh Kashani, Zahra Zandi, Davood Bashash et al. · Cancer Chemotherapy and Pharmacology · 2019 · 56 citations

Medicine, Oncology, Pharmacology +10

The PI3K/AKT/mTOR signaling pathway in breast cancer: Review of clinical trials and latest advances

Ayda Baghery Saghchy Khorasani, Nasim Hafezi, Mohammad‐Javad Sanaei et al. · Cell Biochemistry and Function · 2024 · 33 citations · Full text

Medicine, Oncology, Pharmacology +17

Neurokinin-1 receptor (NK1R) inhibition sensitizes APL cells to anti-tumor effect of arsenic trioxide via restriction of NF-κB axis: Shedding new light on resistance to Aprepitant

Davood Bashash, Ava Safaroghli‐Azar, Samaneh Bayati et al. · The International Journal of Biochemistry & Cell Biology · 2018 · 31 citations

Medicine, Oncology, Pharmacology +10

Anti-leukemic effects of histone deacetylase (HDAC) inhibition in acute lymphoblastic leukemia (ALL) cells: Shedding light on mitigating effects of NF-κB and autophagy on panobinostat cytotoxicity

Mahdieh Mehrpouri, Ava Safaroghli‐Azar, Atieh Pourbagheri‐Sigaroodi et al. · European Journal of Pharmacology · 2020 · 29 citations

Life Sciences, Molecular Biology, Oncology +17

Anticancer effect of pan-PI3K inhibitor on multiple myeloma cells: Shedding new light on the mechanisms involved in BKM120 resistance

Ava Safaroghli‐Azar, Davood Bashash, Alireza Kazemi et al. · European Journal of Pharmacology · 2018 · 23 citations

Medicine, Oncology, Pharmacology +16